List of Studies ( Metabolite:Leu-Gly-Pro)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST002759 | AN004479 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) | Kidney cortex | Rat | Medical College of Wisconsin | Area | |
ST002760 | AN004483 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) | Kidney outer medulla | Rat | Medical College of Wisconsin | Area | |
ST002761 | AN004487 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
ST002306 | AN003768 | Metabolomics profiling of full extracts of bacterial culture supernatants. | Bacterial cells | Bacillus megaterium | Myalgic encephalomyelitis/chronic fatigue syndrome | University of Connecticut | peak area |
ST002306 | AN003768 | Metabolomics profiling of full extracts of bacterial culture supernatants. | Bacterial cells | Enterococcus faecium | Myalgic encephalomyelitis/chronic fatigue syndrome | University of Connecticut | peak area |
ST002307 | AN003769 | Metabolomics profiling of the secondary fractions 4 of bacterial culture supernatants. | Bacterial cells | Bacillus megaterium | Myalgic encephalomyelitis/chronic fatigue syndrome | University of Connecticut | peak area |
ST002307 | AN003769 | Metabolomics profiling of the secondary fractions 4 of bacterial culture supernatants. | Bacterial cells | Enterococcus faecium | Myalgic encephalomyelitis/chronic fatigue syndrome | University of Connecticut | peak area |
ST003024 | AN004958 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 1 | Bacterial cells | Bacteria | Monash Institute of Pharmaceutical Sciences | peak height | |
ST003036 | AN004977 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Bacterial cells | Pseudomonas aeruginosa | Bacterial infection | Monash Institute of Pharmaceutical Sciences | peak height |
ST003053 | AN005006 | Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics | Bacterial cells | Staphylococcus aureus | Bacterial infection | Monash University | peak height |
ST003521 | AN005782 | Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii | Bacterial cells | Acinetobacter baumannii | Bacterial infection | Monash University | peak height |
ST003179 | AN005221 | Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | Peak height |
ST001304 | AN002172 | Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii | Fibroblast cells | Toxoplasma gondii | Parasitic infection | Monash University | Signal Intensity |